HealthTech.
Healthcare technology must earn trust before it earns adoption. The clinicians, procurement committees, patients and regulators who determine market access respond to clinical evidence, peer endorsement and regulatory credibility — not marketing claims.
Sector overview
Clinical credibility
is the only currency that counts.
HealthTech PR operates under constraints that most communications disciplines do not face. Clinical claims must be substantiated. Regulatory statements must be accurate. Patient data must be handled with absolute care. Medical device CE marks, FDA clearances and GDPR compliance are not background context — they are the story.
GlobalCom's HealthTech practice understands the regulated environment that health technology companies operate in. We have built communications programmes for digital health platforms, MedTech manufacturers, diagnostic companies, life sciences software firms and digital therapeutics developers. We know which healthcare trade publications matter to procurement committees, which clinical journals carry weight with hospital decision-makers, and how to position a health technology company accurately in both medical and business media.
Market access in healthcare is not won through advertising. It is won through clinical evidence, regulatory credibility and peer recommendation — all of which have communications components that we help our clients manage.
Three areas of sector-specific focus.
Healthcare & MedTech Media Relations
Accurate, credible coverage in the healthcare publications that clinicians, hospital procurement teams, payers and health system administrators trust — from clinical trade press to health technology business media.
- Healthcare and hospital management trade press
- Medical device and diagnostics industry media
- Digital health and health IT publications
- Pharmacy and life sciences business media
- National health system and NHS/Krankenhaus media
- Health investor and sector finance press
Regulatory & Clinical Communications
Communications support for regulatory milestones — CE mark approvals, FDA clearances, NICE assessments, reimbursement decisions. These are major commercial events that require carefully structured communications to clinical and regulatory audiences.
- Regulatory approval announcement strategy
- Clinical trial results communications
- NICE, HTA and reimbursement decision communications
- FDA 510(k) clearance and PMA announcement support
- MDR and IVDR compliance communications
- Medical congress and symposium communications
Patient & Public Health Communications
Communications that build trust with patients, carers and the public health community. Accurate, compassionate and compliant with the regulatory requirements for direct and indirect patient communications in each market.
- Patient community and advocacy group engagement
- Public health and awareness communications
- Patient data privacy and trust communications
- Health literacy and accessible communications
- Condition-specific media and community relations
- Real-world evidence and outcomes communications
Clinical audiences.
Commercial outcomes.
Clinical and regulatory landscape mapping
We map the regulatory approval pathway, the clinical community, the payer environment and the media landscape in each target market. Healthcare systems vary enormously — what works in Germany does not automatically work in the UK or US.
Audience-specific messaging
Clinical, regulatory and commercial audiences need fundamentally different communications — though the underlying evidence base is the same. We build the messaging architecture that serves all three without contradiction.
In-market delivery
HealthTech-experienced consultants in each target market handle clinical media relations, regulatory communications and commercial PR — in the local language, with knowledge of the local healthcare system.
Measurement and reporting
Monthly reporting on clinical and business media coverage, regulatory communications outcomes, peer and KOL engagement and share of voice in key publications in each market.
Central strategy.
Local expertise.
Healthcare technology market access is a country-by-country process. CE marking opens the EU, but reimbursement decisions are national. NHS procurement works differently from KV procurement in Germany. Hospital Group purchasing in the US is unlike anything in APAC. Communications programmes that do not account for this will underperform.
GlobalCom coordinates HealthTech communications as a single global programme with country-level precision. The senior lead owns the strategy. In-market specialists with healthcare system knowledge execute locally.
- →Communications accurate to regulatory requirements in each market
- →Clinical, commercial and regulatory messaging held consistently
- →Healthcare trade and business media in all major markets
- →Patient and public health communications compliant with local standards
Ready to build your HealthTech communications programme?
Tell us your regulatory pathway, your target markets and your clinical evidence. We will design the programme.